126 related articles for article (PubMed ID: 8408188)
1. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck.
Tsukuda M; Kokatsu T; Ito K; Mochimatsu I; Kubota A; Sawaki S
J Cancer Res Clin Oncol; 1993; 119(12):756-8. PubMed ID: 8408188
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin.
Dreyfuss AI; Clark JR; Fallon BG; Posner MR; Norris CM; Miller D
Cancer; 1987 Dec; 60(12):2869-72. PubMed ID: 2824016
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck.
de Haan LD; De Mulder PH; Vermorken JB; Schornagel JH; Vermey A; Verweij J
Head Neck; 1992; 14(4):273-7. PubMed ID: 1381339
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, tetrahydropyranyl-adriamycin, and cis-platinum in the treatment of head and neck adenocarcinoma.
Kida A; Furusaka T; Endo S; Iida H; Hosokawa T
Auris Nasus Larynx; 1989; 16 Suppl 1():S119-23. PubMed ID: 2604611
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with chemotherapy in advanced salivary gland neoplasms.
Belani CP; Eisenberger MA; Gray WC
Med Pediatr Oncol; 1988; 16(3):197-202. PubMed ID: 2837623
[TBL] [Abstract][Full Text] [Related]
6. CAP therapy for advanced, recurrent and/or metastatic malignant tumors of the head and neck.
Furusaka T; Kida A; Aoyagi M; Makiyama K; Iida H; Miyakogawa M; Kikuchi K; Tomita H
Auris Nasus Larynx; 1986; 13 Suppl 1():S119-26. PubMed ID: 3767770
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
[TBL] [Abstract][Full Text] [Related]
8. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
[TBL] [Abstract][Full Text] [Related]
10. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer.
Creagan ET; Woods JE; Schutt AJ; O'Fallon JR
Cancer; 1983 Dec; 52(11):2007-10. PubMed ID: 6684986
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with CDDP and 5-FU in head and neck cancer.
Furusaka T; Kida A; Iida H; Yokode Y; Kikuchi K; Tomita H
Auris Nasus Larynx; 1986; 13 Suppl 1():S127-33. PubMed ID: 3021095
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
14. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
16. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland.
Airoldi M; Pedani F; Brando V; Gabriele P; Giordano C
Tumori; 1989 Jun; 75(3):252-6. PubMed ID: 2475951
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Sandler S; Bonomi P; Taylor B; Showel J; Slayton R; Lerner H
Cancer Treat Rep; 1984 Sep; 68(9):1163-5. PubMed ID: 6541095
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen.
Creagan ET; Fleming TR; Edmonson JH; Ingle JN; Woods JE
Cancer; 1981 Jun; 47(11):2549-51. PubMed ID: 7196281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
